Page last updated: 2024-08-22

titanium and dehydroxymethylepoxyquinomicin

titanium has been researched along with dehydroxymethylepoxyquinomicin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fukatsu, H; Ichihara, S; Ikegami, A; Izuoka, K; Koide, N; Komatsu, T; Morita, N; Naiki, Y; Tada-Oikawa, S; Ukaji, T; Umezawa, K	1

Other Studies

1 other study(ies) available for titanium and dehydroxymethylepoxyquinomicin

Article	Year
NF‑κB inhibitor DHMEQ inhibits titanium dioxide nanoparticle‑induced interleukin‑1β production: Inhibition of the PM2.5‑induced inflammation model. Molecular medicine reports, 2018, Volume: 18, Issue:6 Topics: Animals; Benzamides; Biomarkers; Caspase 1; Caspase Inhibitors; Cell Line; Cyclohexanones; Disease Models, Animal; Humans; Inflammation; Interleukin-1beta; Macrophages; Models, Molecular; Nanoparticles; NF-kappa B; Particulate Matter; Potassium; Titanium	2018

Article

Year

NF‑κB inhibitor DHMEQ inhibits titanium dioxide nanoparticle‑induced interleukin‑1β production: Inhibition of the PM2.5‑induced inflammation model.

Molecular medicine reports, 2018, Volume: 18, Issue:6

Topics: Animals; Benzamides; Biomarkers; Caspase 1; Caspase Inhibitors; Cell Line; Cyclohexanones; Disease Models, Animal; Humans; Inflammation; Interleukin-1beta; Macrophages; Models, Molecular; Nanoparticles; NF-kappa B; Particulate Matter; Potassium; Titanium

2018